Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sockel, Katja, Wermke, Martin, Radke, Jörgen, Kiani, Alexander, Schaich, Markus, Bornhäuser, Martin, Ehninger, Gerhard, Thiede, Christian, Platzbecker, Uwe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ferrata Storti Foundation 2011
Pynciau:
Letters to the Editor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186324/
https://ncbi.nlm.nih.gov/pubmed/21750085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.044388
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg